Risk for Complications in Patients Hospitalized for COVID-19 With a History of Heart Failure
Patients hospitalized with COVID-19 who have a history of heart failure were found to have greater mortality risk.
Patients hospitalized with COVID-19 who have a history of heart failure were found to have greater mortality risk.
A novel vs reference DAPT regimen after staged PCI was found to reduce the risk for bleeding in patients with acute coronary syndrome.
Worsening renal function may be associated with left ventricular ejection fraction in patients with acute heart failure.
Researchers assessed the risk for obstructive sleep apnea (OSA) among patients with type 2 diabetes and cardiovascular disease taking empagliflozin and further examined the effect of OSA on metabolic, cardiovascular, and renal outcomes.
Atrasentan outperformed both avosentan and bosentan for renoprotection in patients with type 2 diabetic kidney disease.
Gout was not found to be associated with increased risk for cardiovascular complications in patients with peripheral artery disease.
SARS-CoV-2 was detected in the myocardium of patients who had died from COVID-19.
Ritonavir may increase the risk for bradycardia among critically ill patients with COVID-19.